Literature DB >> 9579729

Heterogeneity and underlying mechanism for inotropic action of endothelin-1 in rat ventricular myocytes.

H Katoh1, H Terada, M Iimuro, S Sugiyama, K Qing, H Satoh, H Hayashi.   

Abstract

1. To clarify the mechanisms underlying the positive inotropic action of endothelin-1 (ET-1), we investigated the effect of ET-1 on twitch cell shortening and the Ca2+ transient in rat isolated ventricular myocytes loaded with a fluorescent Ca2+ indicator indo-1. 2. There was a cell-to-cell heterogeneity in response to ET-1. ET-1 (100 nM) increased twitch cell shortening in only 6 of 14 cells (44%) and the increase in twitch cell shortening was always accompanied by an increase in the amplitude of the Ca2+ transient. 3. The ET(A)- and ET(B)-receptors antagonist TAK-044 (100 nM) almost reversed both the ET-1-induced increases in twitch cell shortening and in the Ca2+ transient. In the ET-1 non-responding cells, the amplitude of the Ca2+ transient never increased. 4. Intracellular pH slightly increased (approximately 0.08 unit) after 30 min perfusion of ET-1 in rat ventricular myocytes. However, ET-1 did not change the myofilament responsiveness to Ca2+, which was assessed by (1) the relationship between the Ca2+ transient amplitude and twitch cell shortening, and by (2) the Ca2+ transient-cell shortening phase plane diagram during negative staircase. 5. We concluded that there was a cell-to-cell heterogeneity in the positive inotropic effect of ET-1, and that the ET-receptor-mediated positive inotropic effect was mainly due to an increase in the Ca2+ transient amplitude rather than to an increase in myofilament responsiveness to Ca2+.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9579729      PMCID: PMC1565299          DOI: 10.1038/sj.bjp.0701743

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  2 in total

Review 1.  The cardiovascular physiology and pharmacology of endothelin-1.

Authors:  Eric Thorin; Martine Clozel
Journal:  Adv Pharmacol       Date:  2010

2.  Muscle on a chip: in vitro contractility assays for smooth and striated muscle.

Authors:  Anna Grosberg; Alexander P Nesmith; Josue A Goss; Mark D Brigham; Megan L McCain; Kevin Kit Parker
Journal:  J Pharmacol Toxicol Methods       Date:  2012-04-12       Impact factor: 1.950

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.